<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN"
                           "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer Berlin Heidelberg</PublisherName>
    <PublisherLocation>Berlin/Heidelberg</PublisherLocation>
    <PublisherImprintName>Springer</PublisherImprintName>
  </PublisherInfo>
  <Journal OutputMedium="All">
    <JournalInfo JournalProductType="NonStandardArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>66</JournalID>
      <JournalDOI>10.1007/66.1439-099X</JournalDOI>
      <JournalPrintISSN>0179-7158</JournalPrintISSN>
      <JournalElectronicISSN>1439-099X</JournalElectronicISSN>
      <JournalTitle>Strahlentherapie und Onkologie</JournalTitle>
      <JournalSubTitle>Journal of Radiation Oncology, Biology, Physics</JournalSubTitle>
      <JournalAbbreviatedTitle>Strahlenther Onkol</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="SCH" Type="Primary">Medicine &amp; Public Health</JournalSubject>
        <JournalSubject Code="SCH29056" Priority="1" Type="Secondary">Radiotherapy</JournalSubject>
        <JournalSubject Code="SCH43008" Priority="2" Type="Secondary">Oncology</JournalSubject>
        <SubjectCollection Code="SC11">Medicine</SubjectCollection>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume OutputMedium="All">
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>191</VolumeIDStart>
        <VolumeIDEnd>191</VolumeIDEnd>
        <VolumeIssueCount>12</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular" OutputMedium="All">
        <IssueInfo IssueType="Regular" TocLevels="0">
          <IssueIDStart>6</IssueIDStart>
          <IssueIDEnd>6</IssueIDEnd>
          <IssueArticleCount>12</IssueArticleCount>
          <IssueHistory>
            <OnlineDate>
              <Year>2015</Year>
              <Month>5</Month>
              <Day>30</Day>
            </OnlineDate>
            <PrintDate>
              <Year>2015</Year>
              <Month>5</Month>
              <Day>29</Day>
            </PrintDate>
            <CoverDate>
              <Year>2015</Year>
              <Month>6</Month>
            </CoverDate>
            <PricelistYear>2015</PricelistYear>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>
            <CopyrightYear>2015</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="s00066-014-0809-8" OutputMedium="All">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>809</ArticleID>
            <ArticleDOI>10.1007/s00066-014-0809-8</ArticleDOI>
            <ArticleSequenceNumber>5</ArticleSequenceNumber>
            <ArticleTitle Language="En">Reirradiation for recurrent head and neck cancer with salvage interstitial pulsed-dose-rate brachytherapy</ArticleTitle>
            <ArticleSubTitle Language="En">Long-term results</ArticleSubTitle>
            <ArticleTitle Language="De">Re-Bestrahlung bei rezidivierenden HNO-Tumoren mit interstitieller Salvage Pulsed-dose-rate-Brachytherapie</ArticleTitle>
            <ArticleSubTitle Language="De">Langzeitergebnisse</ArticleSubTitle>
            <ArticleCategory>Original Article</ArticleCategory>
            <ArticleFirstPage>495</ArticleFirstPage>
            <ArticleLastPage>500</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2014</Year>
                <Month>12</Month>
                <Day>19</Day>
              </RegistrationDate>
              <Received>
                <Year>2014</Year>
                <Month>10</Month>
                <Day>13</Day>
              </Received>
              <Accepted>
                <Year>2014</Year>
                <Month>12</Month>
                <Day>19</Day>
              </Accepted>
              <OnlineDate>
                <Year>2015</Year>
                <Month>1</Month>
                <Day>10</Day>
              </OnlineDate>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>
              <CopyrightYear>2015</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <Prefix>Prof. Dr. med.</Prefix>
                  <GivenName>Vratislav</GivenName>
                  <FamilyName>Strnad</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>vratislav.strnad@uk-erlangen.de</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <Prefix>Dr.</Prefix>
                  <GivenName>Michael</GivenName>
                  <FamilyName>Lotter</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Stephan</GivenName>
                  <FamilyName>Kreppner</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <Prefix>Prof. Dr. med.</Prefix>
                  <GivenName>Rainer</GivenName>
                  <FamilyName>Fietkau</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Dept. of Radiation Oncology</OrgDivision>
                <OrgName>University Hospital Erlangen</OrgName>
                <OrgAddress>
                  <Street>Universitätsstr. 27</Street>
                  <Postcode>91052</Postcode>
                  <City>Erlangen</City>
                  <Country>Germany</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En" OutputMedium="All">
              <Heading>Abstract</Heading>
              <AbstractSection ID="ASec1">
                <Heading>Purpose</Heading>
                <Para>To assess the long-term results of protocol-based interstitial pulsed-dose-rate (PDR) brachytherapy as reirradiation combined with simultaneous chemotherapy and interstitial hyperthermia in selected patients with recurrent head and neck tumors.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec2">
                <Heading>Materials and methods</Heading>
                <Para>A total of 104 patients with biopsy-proven recurrent head and neck cancer were treated with interstitial PDR brachytherapy. Salvage surgery had also been undergone by 53/104 (51 %) patients (R1 or R2 resection in &gt; 80 % of patients). Salvage brachytherapy alone was administered in 81 patients (78 %), with a median total dose of 56.7 Gy. Salvage brachytherapy in combination with external beam radiotherapy (EBRT) was performed in 23/104 patients (32 %), using a median total dose of D<Subscript>REF</Subscript> = 24 Gy. Simultaneously to PDR brachytherapy, concomitant chemotherapy was administered in 58/104 (55.8 %) patients. A single session of interstitial hyperthermia was also used to treat 33/104 (31.7 %) patients. The analysis was performed after a median follow-up of 60 months.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec3">
                <Heading>Results</Heading>
                <Para>Calculated according to Kaplan–Meier, local tumor control rates after 2, 5, and 10 years were 92.5, 82.4, and 58.9 %, respectively. Comparing results of salvage PDR brachytherapy with or without simultaneous chemotherapy, the 10-year local control rates were 76 vs. 39 % (<Emphasis Type="Italic">p</Emphasis>= 0014), respectively. No other patient- or treatment-related parameters had a significant influence on treatment results. Soft tissue necrosis or bone necrosis developed in 18/104 (17.3 %) and 11/104 (9.6 %) patients, respectively, but only 3 % of patients required surgical treatment.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec4">
                <Heading>Conclusion</Heading>
                <Para>PDR interstitial brachytherapy with simultaneous chemotherapy is a very effective and, in experienced hands, also a safe treatment modality in selected patients with head and neck cancer in previously irradiated areas.</Para>
              </AbstractSection>
            </Abstract>
            <Abstract ID="Abs2" Language="De" OutputMedium="All">
              <Heading>Zusammenfassung</Heading>
              <AbstractSection ID="ASec5">
                <Heading>Hintergrund und Ziel</Heading>
                <Para>Es erfolgte die Analyse der Langzeitergebnisse einer protokollbasierten interstitiellen Brachytherapie (Re-Bestrahlung) mit simultaner Chemotherapie und interstitieller Hyperthermie bei selektierten Patienten mit HNO-Rezidivtumoren.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec6">
                <Heading>Patienten und Methoden</Heading>
                <Para>Insgesamt wurden 104 Patienten mit histologisch gesichertem Rezidiv eines HNO-Karzinoms mit einer interstitiellen PDR („pulsed-dose-rate“)-Brachytherapie behandelt: 53/104 (51 %) Patienten unterzogen sich auch einer Salvage-Chirurgie (bei &gt; 80 % der Patienten R1/R2-Resektion); 81 Patienten (78 %) wurden mit einer alleinigen Salvage-Brachytherapie bis zu einer Gesamtreferenzdosis von 56,7 Gy (Median) behandelt. Eine Salvage-Brachytherapie in Kombination mit einer perkutanen Strahlentherapie wurde bei 23/104 Patienten (32 %) mit einer Gesamtreferenzdosis in Höhe von Dref=24 Gy durchgeführt. Eine simultane Chemotherapie wurde bei 58/104 (55,8 %) Patienten verabreicht; 33/104 (31,7 %) Patienten wurden ergänzend mit einer interstitiellen Hyperthermie behandelt. Die Analyse wurde nach einem Follow-up im Median von 60 Monaten durchgeführt.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec7">
                <Heading>Ergebnisse</Heading>
                <Para>Die lokalen Tumorkontrollraten nach Kaplan-Meier lagen nach 2, 5 und 10 Jahren bei 92,5, 82,4 und 58,9 %. Im Vergleich der Ergebnisse der Salvage-PDR-Brachytherapie mit oder ohne simultaner Chemotherapie waren die lokalen 10-Jahres-Tumorkontrollraten bei 76 vs. 39 % (<Emphasis Type="Italic">p</Emphasis>= 0014). Keine anderen patientenbezogenen oder therapiebezogenen Parameter hatten einen signifikanten Einfluss auf die Therapieergebnisse. Bei 18/104 (17,3 %) und 11/104 (9,6 %) Patienten haben wir Weichteil- oder Osteoradionekrosen beobachtet, allerdings war nur bei 3 % der Patienten auch eine chirurgische Therapie erforderlich.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec8">
                <Heading>Schlussfolgerung</Heading>
                <Para>Die PDR-interstitielle Brachytherapie mit einer simultanen Chemotherapie ist eine sehr effektive und in erfahrenen Händen auch eine sichere Behandlungsmodalität für selektierte Patienten mit HNO-Rezidivtumoren in bereits bestrahlten Arealen.</Para>
              </AbstractSection>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>Salvage therapy</Keyword>
              <Keyword>Chemotherapy</Keyword>
              <Keyword>Oral cavity</Keyword>
              <Keyword>Interstitial hyperthermia</Keyword>
              <Keyword>Radiotherapy</Keyword>
              <Keyword>Brachytherapy</Keyword>
            </KeywordGroup>
            <KeywordGroup Language="De">
              <Heading>Schlüsselwörter</Heading>
              <Keyword>Salvage-Therapie</Keyword>
              <Keyword>Chemotherapie</Keyword>
              <Keyword>Mundhöhle</Keyword>
              <Keyword>Strahlentherapie</Keyword>
              <Keyword>Interstitielle Hyperthermie</Keyword>
              <Keyword>Brachytherapie</Keyword>
            </KeywordGroup>
          </ArticleHeader>
          <Body>
            <Para>Treatment possibilities for patients with locally recurrent head and neck tumors are limited and, as a consequence, the results are mostly disappointing [<CitationRef CitationID="CR1">1</CitationRef>–<CitationRef CitationID="CR4">4</CitationRef>]. Surgical resection with clear resection margins is rarely possible and because of previous radiation therapy, the scope for reirradiation is also significantly limited. In cases where the radiation oncologist performs reirradiation despite the risks, the setting is usually palliative; consequently, the results of such treatments are very disappointing [<CitationRef CitationID="CR3">3</CitationRef>, <CitationRef CitationID="CR5">5</CitationRef>, <CitationRef CitationID="CR6">6</CitationRef>]. However, as part of a multimodal approach with simultaneous chemotherapy, interstitial hyperthermia, and—where possible and considered clinically useful—in combination with limited surgery, interstitial brachytherapy can be a treatment strategy with curative potential. The aim of the present analysis is to assess the long-term results of protocol-based interstitial pulsed-dose-rate (PDR) brachytherapy combined with simultaneous chemotherapy and interstitial hyperthermia in a group of selected patients.</Para>
            <Section1 ID="Sec1">
              <Heading>Patients and methods</Heading>
              <Section2 ID="Sec2">
                <Heading>Patient selection</Heading>
                <Para>Between 1999 and September 2008, 104 patients with biopsy-proven recurrent head and neck cancer were treated with interstitial PDR brachytherapy at our department.</Para>
                <Para>Eligibility criteria for protocol-based salvage brachytherapy ± simultaneous chemotherapy and interstitial hyperthermia were as follows: histologically confirmed recurrent carcinoma of the head and neck region with no evidence of distant metastasis; tumor size and location suitable for brachytherapy techniques; good performance status and radiation therapy completed more than 3 months previously. Treatment was conducted according the principles of the Helsinki Declaration of 1975 (in its most recently amended version) and Good Clinical Practice guidelines.</Para>
                <Para>Before diagnosis of tumor recurrence and in the context of their previous antitumor treatment, all patients had received radiation therapy up to a total dose of 58–76 Gy (median total dose 65 Gy), with or without chemotherapy. The median time interval between the first and second radiation therapy—i.e. retreatment with brachytherapy—was 30 months (range 3–293 months).</Para>
                <Para>Of the total cohort, 27/104 (26 %) patients were treated for secondary primaries and 77/104 (74 %) for recurrent tumors. Detailed patient characteristics relating to tumor site and stage (Table <InternalRef RefID="Tab1">1</InternalRef>) show that the majority of patients had tumors of the oral cavity (59 %) and large tumors (80 %).<Table Float="Yes" ID="Tab1">
                    <Caption Language="En">
                      <CaptionNumber>Table 1</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Patient characteristics</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <tgroup cols="2">
                      <colspec align="left" colname="c1" colnum="1"/>
                      <colspec align="left" colname="c2" colnum="2"/>
                      <thead>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Characteristic</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>Number of patients, n (%)</SimplePara>
                          </entry>
                        </row>
                      </thead>
                      <tbody>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Age</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>58.9 years (range 21–81 years)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" nameend="c2" namest="c1">
                            <SimplePara>
                              <Emphasis Type="Italic">Gender</Emphasis>
                            </SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Male</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>82 (78.8 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Female</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>22 (21.2 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" nameend="c2" namest="c1">
                            <SimplePara>
                              <Emphasis Type="Italic">Primary tumor location</Emphasis>
                            </SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Tongue (mobile tongue)</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>39 (37.5 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Tongue (base of tongue)</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>29 (27.9 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Floor of mouth</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>22 (21.2 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Tonsil/palate</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>4 (3.8 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Buccal mucosa</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>4 (3.8 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Lip</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>3 (2.9 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Nasopharynx</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>2 (1.9 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Orbit</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>1 (1.0 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" nameend="c2" namest="c1">
                            <SimplePara>
                              <Emphasis Type="Italic">Histopathology</Emphasis>
                            </SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Squamous cell carcinoma</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>98 (94.2 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Sarcoma</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>4 (3.8 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Other</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>2 (1.9 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" nameend="c2" namest="c1">
                            <SimplePara>
                              <Emphasis Type="Italic">Grading</Emphasis>
                            </SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>G1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>10 (9.6 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>G2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>58 (55.8 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>G3</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>28 (26.9 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Unknown</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>8 (7.7 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" nameend="c2" namest="c1">
                            <SimplePara>
                              <Emphasis Type="Italic">Lymphangitis carcinomatosa</Emphasis>
                            </SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>L0</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>27 (26 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>L1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>22 (21.2 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Unknown</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>55 (52.9 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" nameend="c2" namest="c1">
                            <SimplePara>
                              <Emphasis Type="Italic">Stage</Emphasis>
                            </SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>rT1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>21 (20.2 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>rT2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>47 (45.2 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>rT3</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>12 (11.5 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>rT4</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>13 (12.5 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>rTx</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>11 (11.6 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>rN0</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>74 (71.2 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>rN+</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>23 (22.2 %)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>rNx</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>7 (6.8 %)</SimplePara>
                          </entry>
                        </row>
                      </tbody>
                    </tgroup>
                  </Table>
                </Para>
              </Section2>
              <Section2 ID="Sec3">
                <Heading>Treatment</Heading>
                <Para>Salvage surgery had been undergone by 53/104 (51 %) patients. The status of the resection margins was assessed in all cases: unfortunately, microscopic (R1) or macroscopic (R2) residual disease was found in 19 % (10/53) and 62 % (33/53) of patients, respectively, before the start of salvage interstitial brachytherapy.</Para>
                <Para>All patients were treated with interstitial PDR brachytherapy with or without external beam radiotherapy (EBRT). The implant method has been described in detail previously [<CitationRef CitationID="CR7">7</CitationRef>, <CitationRef CitationID="CR8">8</CitationRef>]. In all cases, the dose was specified according to International Commission on Radiation Units (ICRU) 58 (Paris system; [<CitationRef CitationID="CR9">9</CitationRef>]). A dose per pulse (dp) of 0.40–0.70 Gy (median 0.55 Gy) was administered up to a median total dose of 55 Gy (ranging between 10 Gy and 66.3 Gy). The pulses were delivered for 24 h per day, with a time interval of 1 h between two pulses. The median implant volume, as measured by the volume of the reference 85 % isodose, was 26.3 cm<Superscript>3</Superscript> (range 7.3–77.1 cm<Superscript>3</Superscript>). Further documented brachytherapy parameters included the volume receiving &gt;150% of the prescribed dose (V<Subscript>150</Subscript>), the dose nonuniformity ratio (DNR), the coverage index (V<Subscript>100</Subscript>), and the D<Subscript>90</Subscript>. Their median values were 7.1 cm<Superscript>3</Superscript>, 0.26, 92.9, and 98.5 %, respectively.</Para>
                <Para>Of the total group, 81 patients (78 %) received salvage brachytherapy alone, using a median total dose of 56.7 Gy with dp values in the range of 0.45–0.7 Gy/h/24 h (median 0.55 Gy/h). Salvage brachytherapy in combination with EBRT was performed in 23 patients (32 %), using a median total dose of D<Subscript>REF </Subscript>= 24 Gy (dp<Subscript>median</Subscript> = 0.5 Gy, range 0.4–0.7 Gy). Brachytherapy was administered after a median of 7 days after EBRT. EBRT was performed up to a median reference dose of 40 Gy (range 20–67 Gy).</Para>
                <Para>Simultaneously to PDR brachytherapy, concomitant chemotherapy was administered in 58/104 (55.8 %) patients. From day 1 to day 5 of PDR brachytherapy, the majority of patients received one course of cisplatin (20 mg/m<Superscript>2</Superscript>) or carboplatin (AUC1) as a short intravenous infusion each day, and 5-flourouracil 800 mg/m<Superscript>2</Superscript> was given by continuous infusion for 120 h. In 4 patients, chemotherapy regimens with cisplatin/paclitaxel or cisplatin/mitomycin were used for individual reasons.</Para>
                <Para>In 33/104 (31.7 %) patients, a single session of interstitial hyperthermia was administered directly after PDR brachytherapy was finished. Interstitial dipole antennas (6–11, median 7) were used to deliver treatment and multipoint temperature sensors were used to measure the temperature. Each patient was maintained at the target temperature for a median of 60 min. The median temperature attained was 42.0 °C.</Para>
                <Para>All patients were followed up closely to analyze acute and late toxicity, local control, and survival. The analysis was performed after a median follow-up of 60 months (24–162 months). The median follow-up was calculated from the first day of reirradiation to the date of the last follow-up.</Para>
                <Para>The primary endpoints of the study were analysis of local tumor control rates and late side effects. As a secondary endpoint the Kaplan–Meier analysis was performed to estimate disease-free and overall survival after 5 years.</Para>
              </Section2>
              <Section2 ID="Sec4">
                <Heading>Assessment of tumor response and side effects</Heading>
                <Para>All patients underwent repeated examinations during and after therapy for evaluation of tumor response and side effects. Following completion of treatment, patients were followed at 3-month intervals for 24 months and at 6-months intervals thereafter for at least a further 36 months, to analyze late side effects, local control, and survival. The side effects were scored according to Lent Soma criteria.</Para>
              </Section2>
              <Section2 ID="Sec5">
                <Heading>Statistics</Heading>
                <Para>Data management and statistics were carried out with PASW Statistics for MS Windows (SPSS Inc., Chicago, IL, USA), release 18.0.0. For statistical comparisons between groups, the Mann–Whitney U and Pearson’s χ-square tests were used, as appropriate. Survival probability was estimated using the Kaplan–Meier method [<CitationRef CitationID="CR10">10</CitationRef>], using the log-rank test and Cox regression multivariate analyses to compare two or more groups.</Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec6">
              <Heading>Results</Heading>
              <Para>All the patients received the entire intended course of salvage PDR brachytherapy ± simultaneous chemotherapy and hyperthermia. There were no treatment-related deaths.</Para>
              <Para>After a median follow-up of 60 months, the 2-, 5-, and 10-year local tumor control rates calculated according to Kaplan–Meier were 92.5, 82.4, and 58.9 %, respectively (Fig. <InternalRef RefID="Fig1">1</InternalRef>). The 5-year disease-free and overall survival rates were 81 and 21 %, respectively. A detailed analysis of causes of deaths shows that 4 % of patients died on other tumor, 12 % on metastases, 54 % on other causesand only minority of all patients (30%) died on local recurrent tumor.<Figure Category="Standard" Float="Yes" ID="Fig1">
                  <Caption Language="En">
                    <CaptionNumber>Fig. 1</CaptionNumber>
                    <CaptionContent>
                      <SimplePara>Local recurrence-free survival rates according to Kaplan–Meier</SimplePara>
                    </CaptionContent>
                  </Caption>
                  <MediaObject ID="MO1">
                    <ImageObject Color="Color" FileRef="MediaObjects/66_2014_809_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                  </MediaObject>
                </Figure>
              </Para>
              <Para>When comparing patients treated for second primaries and patients with recurrent tumors, we found a difference in 5-year local recurrence-free survival rates (70 vs. 46 %, respectively), but this difference was not statistically significant (<Emphasis Type="Italic">p</Emphasis>= 0.63). Similarly, we found no statistically significant difference (neither in log-rank test nor in multivariate Cox proportional hazards regression analysis) in the probability of local recurrence in patients subgrouped by different brachytherapy quality parameters, by anatomical site of the tumor, tumor size, resection margins clear versus positive, tumor histology, lymph nodes positive versus negative, tumor grade, or lymphangitis carcinomatosa. Additionally, the application of hyperthermia did not have a significant influence on treatment results. In contrast, the simultaneous application of chemotherapy during PDR brachytherapy significantly improved treatment results.</Para>
              <Para>Comparing results of salvage PDR brachytherapy with or without simultaneous chemotherapy, the 10-year local control rates according to Kaplan–Meier were 76 vs. 39 % (<Emphasis Type="Italic">p</Emphasis>= 0.014), respectively (Fig. <InternalRef RefID="Fig2">2</InternalRef>). Simultaneous chemotherapy was the only factor shown to have an influence on the local recurrence rates achieved by salvage brachytherapy, as was also confirmed using multivariate Cox proportional hazards regression analysis (<Emphasis Type="Italic">p</Emphasis>= 0015).<Figure Category="Standard" Float="Yes" ID="Fig2">
                  <Caption Language="En">
                    <CaptionNumber>Fig. 2</CaptionNumber>
                    <CaptionContent>
                      <SimplePara>Local recurrence-free survival rates according to Kaplan–Meier in patients with or without simultaneous chemotherapy (<Emphasis Type="Italic">blue line</Emphasis> brachytherapy without chemotherapy, <Emphasis Type="Italic">red line</Emphasis> brachytherapy with chemotherapy; <Emphasis Type="Italic">p</Emphasis>= 0.01)</SimplePara>
                    </CaptionContent>
                  </Caption>
                  <MediaObject ID="MO2">
                    <ImageObject Color="Color" FileRef="MediaObjects/66_2014_809_Fig2_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                  </MediaObject>
                </Figure>
              </Para>
              <Para>Regarding serious late side effects, 18/104 (17.3 %) patients developed soft tissue necrosis, but only 3 (3/104, 2.9 %) developed soft tissue ulceration needing surgical treatment. Furthermore, in 11/104 (9.6 %) patients, we observed radiation-induced bone necrosis, but only in 3 patients (3/104, 2.9 %) was surgical treatment necessary.</Para>
              <Para>All patients scheduled for simultaneous chemotherapy received the intended dose of chemotherapy. Generally, simultaneous chemotherapy was well tolerated, with only transient side effects. Bone marrow suppression manifested as leucopenia, anemia, and thrombocytopenia. We observed no grade III or IV side effects.</Para>
            </Section1>
            <Section1 ID="Sec7">
              <Heading>Discussion</Heading>
              <Para>The majority of patients with persistent or recurrent head and neck cancer have a very poor prognosis. Retreating these patients with salvage surgery or salvage radiation therapy carries a significant risk of morbidity. Radiation therapy of head and neck cancer in previously irradiated areas is a complicated treatment, associated with a significant risk of serious acute and late side effects [<CitationRef CitationID="CR3">3</CitationRef>, <CitationRef CitationID="CR5">5</CitationRef>, <CitationRef CitationID="CR8">8</CitationRef>, <CitationRef CitationID="CR11">11</CitationRef>–<CitationRef CitationID="CR13">13</CitationRef>]. Although salvage EBRT (re-EBRT) is technically possible, it is rarely attempted because of its low effectiveness and the associated high complication rates [<CitationRef CitationID="CR4">4</CitationRef>, <CitationRef CitationID="CR14">14</CitationRef>–<CitationRef CitationID="CR16">16</CitationRef>] Therefore, the majority of patients are treated with palliative or supportive care only. However, if selected carefully, a reasonable number of these patients may have a chance of long-term disease control. By virtue of the strictly focal application of radiation dose and the very steep dose dropoff in the neighboring tissues, brachytherapy can offer selected patients the possibility of reirradiation up to high doses (@ 60 Gy), without unavoidably high complication rates in the surrounding healthy tissues. There is still no clear evidence on whether simultaneous hyperthermia or concomitant chemotherapy can improve the results of brachytherapy [<CitationRef CitationID="CR5">5</CitationRef>, <CitationRef CitationID="CR17">17</CitationRef>–<CitationRef CitationID="CR19">19</CitationRef>]. Only very scant data relating to the combination of brachytherapy with chemotherapy and interstitial hyperthermia are available in the literature [<CitationRef CitationID="CR5">5</CitationRef>, <CitationRef CitationID="CR20">20</CitationRef>–<CitationRef CitationID="CR22">22</CitationRef>] and unfortunately, none of these analyses have found significant improvement in the results of salvage brachytherapy. Generally speaking, the reported local control rates of salvage brachytherapy for previously irradiated recurrent head and neck cancer vary very widely—between 14 and 90 % after 2–5 years [<CitationRef CitationID="CR23">23</CitationRef>–<CitationRef CitationID="CR29">29</CitationRef>].</Para>
              <Para>Only few groups [<CitationRef CitationID="CR30">30</CitationRef>–<CitationRef CitationID="CR33">33</CitationRef>] have reported very good local control rates of up to 80 % using salvage brachytherapy. Mazeron et al. [<CitationRef CitationID="CR30">30</CitationRef>] described local control rates of up to 72 % at 2 years in previously irradiated patients. In 73 patients with velotonsillar carcinoma in a previously irradiated field, Peiffert et al. [<CitationRef CitationID="CR32">32</CitationRef>] reported 5-year actuarial local control rates of 80 and 67 % for T1 N0 and T2 N0, respectively (only grade 2 complications occurred in 13 % of patients). Narayna et al. [<CitationRef CitationID="CR33">33</CitationRef>] and Pommier et al. [<CitationRef CitationID="CR31">31</CitationRef>] described equally good results in a small patient group. Our earlier published results [<CitationRef CitationID="CR34">34</CitationRef>–<CitationRef CitationID="CR36">36</CitationRef>] proved that the combination of PDR brachytherapy with simultaneous chemotherapy and interstitial hyperthermia leads to high local control rates (up to 79 %) accompanied with acceptable rates of serious late side effects (10–18 %).</Para>
              <Para>In contrast to these excellent results, some other groups have reported significant severe late side effects after salvage brachytherapy as reirradiation [<CitationRef CitationID="CR1">1</CitationRef>, <CitationRef CitationID="CR3">3</CitationRef>, <CitationRef CitationID="CR21">21</CitationRef>, <CitationRef CitationID="CR37">37</CitationRef>–<CitationRef CitationID="CR39">39</CitationRef>]. Puthawala et al. [<CitationRef CitationID="CR25">25</CitationRef>], Mazeron et al. [<CitationRef CitationID="CR30">30</CitationRef>], and Levendag et al. [<CitationRef CitationID="CR40">40</CitationRef>] reported moderate or severe side effects complications were in 27–28 %. Bartochowska et al. [<CitationRef CitationID="CR5">5</CitationRef>] stated an overall complication rate of 35 % after salvage brachytherapy with palliative intention. Other authors reported even higher rates of severe side effects in up to 60 % of patients [<CitationRef CitationID="CR1">1</CitationRef>–<CitationRef CitationID="CR3">3</CitationRef>, <CitationRef CitationID="CR21">21</CitationRef>, <CitationRef CitationID="CR37">37</CitationRef>–<CitationRef CitationID="CR39">39</CitationRef>, <CitationRef CitationID="CR41">41</CitationRef>–<CitationRef CitationID="CR43">43</CitationRef>]. In this context, one important fact should be borne in mind: serious late side effects appear more often after high-dose-rate (HDR) salvage brachytherapy than after PDR-salvage brachytherapy [<CitationRef CitationID="CR5">5</CitationRef>, <CitationRef CitationID="CR8">8</CitationRef>, <CitationRef CitationID="CR40">40</CitationRef>, <CitationRef CitationID="CR44">44</CitationRef>–<CitationRef CitationID="CR47">47</CitationRef>].</Para>
              <Para>Regarding effectiveness (5-year local control rate of about 80 %) and the rate of side effects (soft tissue necrosis 3–17 % and bone necrosis 3–10 %), the current results are quite comparable with the best previously published results [<CitationRef CitationID="CR31">31</CitationRef>, <CitationRef CitationID="CR32">32</CitationRef>, <CitationRef CitationID="CR44">44</CitationRef>, <CitationRef CitationID="CR48">48</CitationRef>]. We believe that the following features of our treatment concept are crucial: the use of brachytherapy as PDR brachytherapy (as is generally known, PDR brachytherapy is a modality which unites the biological advantages of low-dose-rate, LDR, brachytherapy and the technologic advantages of HDR brachytherapy), stringent quality assurance [<CitationRef CitationID="CR7">7</CitationRef>, <CitationRef CitationID="CR8">8</CitationRef>, <CitationRef CitationID="CR49">49</CitationRef>, <CitationRef CitationID="CR50">50</CitationRef>, <CitationRef CitationID="CR51">51</CitationRef>], and use of simultaneous chemotherapy. Whether the use of hyperthermia can also significantly improve the efficacy of salvage interstitial brachytherapy, is not clear. In order to address the later issue, more patients are necessary for valid statistical analysis.</Para>
            </Section1>
            <Section1 ID="Sec8" Type="Conclusion">
              <Heading>Conclusion</Heading>
              <Para>PDR interstitial brachytherapy with simultaneous chemotherapy is a very effective and, in experienced hands, also a safe treatment modality in selected patients with head and neck cancer in previously irradiated areas.</Para>
            </Section1>
          </Body>
          <BodyRef FileRef="BodyRef/PDF/66_2014_Article_809.pdf" OutputMedium="All" PDFType="Typeset" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Ethics>
              <Heading>Compliance with ethical guidelines</Heading>
              <FormalPara RenderingStyle="Style1">
                <Heading>Conflict of interest</Heading>
                <Para>V. Strnad, M. Lotter, S. Kreppner, and R. Fietkau state that there are no conflicts of interest. All studies on humans described in the present manuscript were carried out with the approval of the responsible ethics committee and in accordance with national law and the Helsinki Declaration of 1975 (in its current, revised form). Informed consent was obtained from all patients included in studies.</Para>
              </FormalPara>
            </Ethics>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PG</Initials>
                    <FamilyName>Cornes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HJ</Initials>
                    <FamilyName>Cox</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PR</Initials>
                    <FamilyName>Rhys Evans</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Salvage treatment for inoperable neck nodes in head and neck cancer using combined iridium 192 brachytherapy and surgical reconstruction</ArticleTitle>
                  <JournalTitle>Br J Surg</JournalTitle>
                  <VolumeID>83</VolumeID>
                  <FirstPage>1620</FirstPage>
                  <LastPage>1622</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/bjs.1800831141</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2s7mslSjsA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>9014691</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cornes PG, Cox HJ, Rhys Evans PR (1996) Salvage treatment for inoperable neck nodes in head and neck cancer using combined iridium 192 brachytherapy and surgical reconstruction. Br J Surg 83:1620–1622</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Housset</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Barret</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Brunel</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Split course interstitial brachytherapy with a source shift: the results of a new technique for salvage irradiation in recurrent inoperable cervical lymphadenopathy greater than or equal to 4</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>1071</FirstPage>
                  <LastPage>1074</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0360-3016(92)90810-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK383htVemsQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>1555955</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Housset M, Barret JM, Brunel P et al (1992) Split course interstitial brachytherapy with a source shift: the results of a new technique for salvage irradiation in recurrent inoperable cervical lymphadenopathy greater than or equal to 4 cm diameter in 23 patients. Int J Radiat Oncol Biol Phys 22:1071–1074</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PD</Initials>
                    <FamilyName>Righi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EC</Initials>
                    <FamilyName>Weisberger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PR</Initials>
                    <FamilyName>Krakovits</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Wound complications associated with brachytherapy for primary or salvage treatment of head and neck cancer</ArticleTitle>
                  <JournalTitle>Laryngoscope</JournalTitle>
                  <VolumeID>107</VolumeID>
                  <FirstPage>1464</FirstPage>
                  <LastPage>1468</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00005537-199711000-00008</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1c%2FjsVehtg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>9369391</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Righi PD, Weisberger EC, Krakovits PR et al (1997) Wound complications associated with brachytherapy for primary or salvage treatment of head and neck cancer. Laryngoscope 107:1464–1468</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Platteaux</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Dirix</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Vanstraelen</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2011</Year>
                  <ArticleTitle Language="En">Outcome after re-irradiation of head and neck cancer patients</ArticleTitle>
                  <JournalTitle>Strahlenth Onkol</JournalTitle>
                  <VolumeID>187</VolumeID>
                  <FirstPage>23</FirstPage>
                  <LastPage>31</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s00066-010-2139-9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Platteaux N, Dirix P, Vanstraelen B et al (2011) Outcome after re-irradiation of head and neck cancer patients. Strahlenth Onkol 187:23–31</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Bartochowska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Wierzbicka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Skowronek</FamilyName>
                  </BibAuthorName>
                  <Year>2012</Year>
                  <ArticleTitle Language="En">High-dose-rate and pulsed-dose-rate brachytherapy in palliative treatment of head and neck cancers</ArticleTitle>
                  <JournalTitle>Brachytherapy</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>137</FirstPage>
                  <LastPage>143</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.brachy.2011.09.006</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>22104354</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bartochowska A, Wierzbicka M, Skowronek J (2012) High-dose-rate and pulsed-dose-rate brachytherapy in palliative treatment of head and neck cancers. Brachytherapy 11:137–143</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RE</Initials>
                    <FamilyName>Friedrich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Krull</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Schwarz</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Salvagebehandlung fortgeschrittener Plattenepithelkarzinome der Mundhohle und des Oropharynx. Ergebnisse der interstitiellen HDR Brachytherapie in Kombination mit ablativer Tumorchirurgie</ArticleTitle>
                  <JournalTitle>Strahlenther Onkol</JournalTitle>
                  <VolumeID>173</VolumeID>
                  <FirstPage>507</FirstPage>
                  <LastPage>512</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF03038466</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1c%2FhsVOnuw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>9381359</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Friedrich RE, Krull A, Schwarz R (1997) Salvagebehandlung fortgeschrittener Plattenepithelkarzinome der Mundhohle und des Oropharynx. Ergebnisse der interstitiellen HDR Brachytherapie in Kombination mit ablativer Tumorchirurgie. Strahlenther Onkol 173:507–512</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Strnad</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lotter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GG</Initials>
                    <FamilyName>Grabenbauer</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Early results of pulsed-dose-rate interstitial brahytherapy for head and neck malignancies after limited surgery</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>46</VolumeID>
                  <FirstPage>27</FirstPage>
                  <LastPage>30</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0360-3016(99)00417-4</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3c7itVWlsw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>10656368</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Strnad V, Lotter M, Grabenbauer GG et al (2000) Early results of pulsed-dose-rate interstitial brahytherapy for head and neck malignancies after limited surgery. Int J Radiat Oncol Biol Phys 46:27–30</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Strnad</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Geiger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lotter</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Role of brachytherapy for head and neck cancer: retreatment in previously irradiated area</ArticleTitle>
                  <JournalTitle>Brachytherapy</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>158</FirstPage>
                  <LastPage>163</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1538-4721(03)00132-6</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>15062138</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Strnad V, Geiger M, Lotter M et al (2003) Role of brachytherapy for head and neck cancer: retreatment in previously irradiated area. Brachytherapy 2:158–163</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9</CitationNumber>
                <BibUnstructured>ICRU (1997) Report 58: dose and volume specification for reporting interstitial therapy. Bethesda, Maryland, USA</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Kaplan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Meyer</FamilyName>
                  </BibAuthorName>
                  <Year>1958</Year>
                  <ArticleTitle Language="En">Nonparametric estimation from incomplete observations</ArticleTitle>
                  <JournalTitle>J Am Stat Assoc</JournalTitle>
                  <VolumeID>53</VolumeID>
                  <FirstPage>457</FirstPage>
                  <LastPage>481</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1080/01621459.1958.10501452</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kaplan E, Meyer P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Pellizzon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JV</Initials>
                    <FamilyName>Salvajoli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Kowalski</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy</ArticleTitle>
                  <JournalTitle>Radiat Oncol</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <FirstPage>27</FirstPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1186/1748-717X-1-27</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>1559626</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>16895605</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pellizzon AC, Salvajoli JV, Kowalski LP et al (2006) Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy. Radiat Oncol 1:27</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JJ</Initials>
                    <FamilyName>Mazeron</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Crook</FamilyName>
                  </BibAuthorName>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">Effect of dose rate on local control and necrosis in the reirradiation of faucial arch squamous cell carcinoma with interstitial iridium 192</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>1275</FirstPage>
                  <LastPage>1279</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0360-3016(90)90469-Z</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK3c3ntVSntA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>2347736</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mazeron JJ, Crook J (1990) Effect of dose rate on local control and necrosis in the reirradiation of faucial arch squamous cell carcinoma with interstitial iridium 192. Int J Radiat Oncol Biol Phys 18:1275–1279</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Skowronek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Wierzbicka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Milecki</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Palliative HDR and PDR brachytherapy in treatment of head and neck cancer relapses</ArticleTitle>
                  <JournalTitle>Otolaryngol Pol</JournalTitle>
                  <VolumeID>58</VolumeID>
                  <FirstPage>721</FirstPage>
                  <LastPage>729</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15603380</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Skowronek J, Wierzbicka M, Milecki P et al (2004) Palliative HDR and PDR brachytherapy in treatment of head and neck cancer relapses. Otolaryngol Pol 58:721–729</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DT</Initials>
                    <FamilyName>Chua</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Sham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DL</Initials>
                    <FamilyName>Kwong</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Locally recurrent nasopharyngeal carcinoma: treatment results for patients with computed tomography assessment</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <FirstPage>379</FirstPage>
                  <LastPage>386</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0360-3016(98)00063-7</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1c3mvVeksg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>9607354</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Chua DT, Sham J, Kwong DL (1998) Locally recurrent nasopharyngeal carcinoma: treatment results for patients with computed tomography assessment. Int J Radiat Oncol Biol Phys 41:379–386</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Dawson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LL</Initials>
                    <FamilyName>Myers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CR</Initials>
                    <FamilyName>Bradford</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Conformal re irradiation of recurrent and new primary head and neck cancer</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phy</JournalTitle>
                  <VolumeID>50</VolumeID>
                  <FirstPage>377</FirstPage>
                  <LastPage>385</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0360-3016(01)01456-0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3M3psF2gtQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dawson LA, Myers LL, Bradford CR et al (2001) Conformal re irradiation of recurrent and new primary head and neck cancer. Int J Radiat Oncol Biol Phy 50:377–385</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EH</Initials>
                    <FamilyName>Tan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Adelstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Saxton</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Concurrent chemoradiotherapy for salvage in relapsed squamous cell head and neck cancer</ArticleTitle>
                  <JournalTitle>Cancer Invest</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>422</FirstPage>
                  <LastPage>428</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.3109/07357909709047581</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2svmt1ersw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>9316624</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tan EH, Adelstein DJ, Saxton JP et al (1997) Concurrent chemoradiotherapy for salvage in relapsed squamous cell head and neck cancer. Cancer Invest 15:422–428</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Gandia</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Wibault</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Guillot</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer</ArticleTitle>
                  <JournalTitle>Head Neck</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>8</FirstPage>
                  <LastPage>15</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/hed.2880150103</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK3s7gs1OqtA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>7677989</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gandia D, Wibault P, Guillot T et al (1993) Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer. Head Neck 15:8–15</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MH</Initials>
                    <FamilyName>Seegenschmiedt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Sauer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Fietkau</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Interstitial thermal radiation therapy: 5-year experience with head and neck tumors</ArticleTitle>
                  <JournalTitle>Radiology</JournalTitle>
                  <VolumeID>184</VolumeID>
                  <FirstPage>795</FirstPage>
                  <LastPage>804</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1148/radiology.184.3.1509070</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK38zns1ajtA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>1509070</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Seegenschmiedt MH, Sauer R, Fietkau R et al (1992) Interstitial thermal radiation therapy: 5-year experience with head and neck tumors. Radiology 184:795–804</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Emami</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Scott</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CA</Initials>
                    <FamilyName>Perez</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>34</VolumeID>
                  <FirstPage>1097</FirstPage>
                  <LastPage>1104</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0360-3016(95)02137-X</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK287ot1alsg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>8600093</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Emami B, Scott C, Perez CA et al (1996) Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group. Int J Radiat Oncol Biol Phys 34:1097–1104</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Hepel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Syed</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Puthawala</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>62</VolumeID>
                  <FirstPage>1444</FirstPage>
                  <LastPage>1450</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ijrobp.2004.12.078</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>16029806</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hepel JT, Syed AM, Puthawala A et al (2005) Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 62:1444–1450</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Bollet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lapeyre</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Marchal</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Cervical lymph node relapses of head and neck squamous cell carcinoma: is brachytherapy a therapeutic option?</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>51</VolumeID>
                  <FirstPage>1305</FirstPage>
                  <LastPage>1312</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0360-3016(01)01725-4</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3Mnot1ymsQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>11728691</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bollet MA, Lapeyre M, Marchal C et al (2001) Cervical lymph node relapses of head and neck squamous cell carcinoma: is brachytherapy a therapeutic option? Int J Radiat Oncol Biol Phys 51:1305–1312</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Sakurai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Mitsuhashi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Tamaki</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Clinical application of low dose-rate brachytherapy combined with simultaneous mild temperature hyperthermia</ArticleTitle>
                  <JournalTitle>Anticancer Res</JournalTitle>
                  <VolumeID>21</VolumeID>
                  <FirstPage>679</FirstPage>
                  <LastPage>684</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3M3gvFGnsg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>11299825</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sakurai H, Mitsuhashi N, Tamaki Y et al (2001) Clinical application of low dose-rate brachytherapy combined with simultaneous mild temperature hyperthermia. Anticancer Res 21:679–684</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Glatzel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Büntzel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Schröder</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer</ArticleTitle>
                  <JournalTitle>Laryngoscope</JournalTitle>
                  <VolumeID>112</VolumeID>
                  <FirstPage>1366</FirstPage>
                  <LastPage>1371</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00005537-200208000-00008</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>12172246</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Glatzel M, Büntzel J, Schröder D et al (2002) High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer. Laryngoscope 112:1366–1371</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Fischer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Stuben</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Stuschke</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Brachytherapy with (192)Iridium in the treatment of recurrent nasopharyngeal carcinoma</ArticleTitle>
                  <JournalTitle>Laryngorhinootologie</JournalTitle>
                  <VolumeID>81</VolumeID>
                  <FirstPage>106</FirstPage>
                  <LastPage>110</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1055/s-2002-23115</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD387otFCmtg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>11914947</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fischer M, Stuben G, Stuschke M (2002) Brachytherapy with (192)Iridium in the treatment of recurrent nasopharyngeal carcinoma. Laryngorhinootologie 81:106–110</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Puthawala</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Syed</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Gamie</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Interstitial low dose rate brachytherapy as a salvage treatment for recurrent head and neck cancers: long term results</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>51</VolumeID>
                  <FirstPage>354</FirstPage>
                  <LastPage>362</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0360-3016(01)01637-6</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3Mrit1Sktw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>11567809</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Puthawala A, Syed AM, Gamie S et al (2001) Interstitial low dose rate brachytherapy as a salvage treatment for recurrent head and neck cancers: long term results. Int J Radiat Oncol Biol Phys 51:354–362</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Grimard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Esche</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Lamothe</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2009</Year>
                  <ArticleTitle Language="En">Interstitial brachytherapy in the management of persistent head and neck disease after definitive external beam radiation therapy</ArticleTitle>
                  <JournalTitle>Brachytherapy</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>284</FirstPage>
                  <LastPage>289</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.brachy.2008.12.007</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>19446500</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Grimard L, Esche B, Lamothe A et al (2009) Interstitial brachytherapy in the management of persistent head and neck disease after definitive external beam radiation therapy. Brachytherapy 8:284–289</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Grimard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Lamothe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Esche</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">Brachytherapy in the retreatment of patients with new primary head and neck cancer</ArticleTitle>
                  <JournalTitle>J Otolaryngol</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <FirstPage>327</FirstPage>
                  <LastPage>335</LastPage>
                  <Occurrence Type="PID">
                    <Handle>18076842</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Grimard L, Lamothe A, Esche B et al (2007) Brachytherapy in the retreatment of patients with new primary head and neck cancer. J Otolaryngol 36:327–335</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ME</Initials>
                    <FamilyName>Kupferman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WH</Initials>
                    <FamilyName>Morrison</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Santillan</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers</ArticleTitle>
                  <JournalTitle>Cancer</JournalTitle>
                  <VolumeID>109</VolumeID>
                  <FirstPage>2052</FirstPage>
                  <LastPage>2057</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/cncr.22648</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>17407106</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kupferman ME, Morrison WH, Santillan AA et al (2007) The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers. Cancer 109:2052–2057</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KM</Initials>
                    <FamilyName>Gestel</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Buurman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Pijls</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">Locally advanced verrucous carcinoma of the oral cavity: treatment using customized mold HDR brachytherapy instead of hemi-maxillectomy</ArticleTitle>
                  <JournalTitle>Strahlenther Onkol</JournalTitle>
                  <VolumeID>189</VolumeID>
                  <FirstPage>894</FirstPage>
                  <LastPage>898</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s00066-013-0412-4</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>23963206</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>van Gestel KM, Buurman DJ, Pijls R et al (2013) Locally advanced verrucous carcinoma of the oral cavity: treatment using customized mold HDR brachytherapy instead of hemi-maxillectomy. Strahlenther Onkol 189:894–898</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JJ</Initials>
                    <FamilyName>Mazeron</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Lamglois</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Glaubiger</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1987</Year>
                  <ArticleTitle Language="En">Salvage irradiation of oropharyngeal cancers using Iridium 192 wire implants: 5-year results of 70 cases</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <FirstPage>957</FirstPage>
                  <LastPage>962</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0360-3016(87)90031-9</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL2s3kvF2lsg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>3597158</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mazeron JJ, Lamglois D, Glaubiger D et al (1987) Salvage irradiation of oropharyngeal cancers using Iridium 192 wire implants: 5-year results of 70 cases. Int J Radiat Oncol Biol Phys 13:957–962</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Pommier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Bolot</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Martel</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Salvage brachytherapy of posterior pharyngeal wall squamous cell carcinoma in a previously irradiated area</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>38</VolumeID>
                  <FirstPage>53</FirstPage>
                  <LastPage>58</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0360-3016(97)00219-8</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2szlsFGhsQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>9212004</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pommier P, Bolot G, Martel I et al (1997) Salvage brachytherapy of posterior pharyngeal wall squamous cell carcinoma in a previously irradiated area. Int J Radiat Oncol Biol Phys 38:53–58</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Peiffert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Pernot</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Malissard</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Salvage irradiation by brachytherapy of velotonsillar squamous cell carcinoma in a previously irradiated field: results in 73 cases</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <FirstPage>681</FirstPage>
                  <LastPage>686</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0360-3016(94)90554-1</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2czhsVGrtg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>8040013</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Peiffert D, Pernot M, Malissard L et al (1994) Salvage irradiation by brachytherapy of velotonsillar squamous cell carcinoma in a previously irradiated field: results in 73 cases. Int J Radiat Oncol Biol Phys 29:681–686</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>33</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Narayana</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GN</Initials>
                    <FamilyName>Cohen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Zaider</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers–preliminary results</ArticleTitle>
                  <JournalTitle>Brachytherapy</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>157</FirstPage>
                  <LastPage>163</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.brachy.2006.12.001</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>17434110</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Narayana A, Cohen GN, Zaider M et al (2007) High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers–preliminary results. Brachytherapy 6:157–163</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>34</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Strnad</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lotter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Kreppner</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2014</Year>
                  <ArticleTitle Language="En">Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma</ArticleTitle>
                  <JournalTitle>Brachytherapy</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <FirstPage>187</FirstPage>
                  <LastPage>195</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.brachy.2013.10.008</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>24211123</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Strnad V, Lotter M, Kreppner S et al (2014) Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma. Brachytherapy 13:187–195</BibUnstructured>
              </Citation>
              <Citation ID="CR35">
                <CitationNumber>35</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Strnad</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Geiger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lotter</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Role of brachytherapy for head and neck cancer: retreatment in previously irradiated area</ArticleTitle>
                  <JournalTitle>Brachytherapy</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>158</FirstPage>
                  <LastPage>163</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1538-4721(03)00132-6</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>15062138</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Strnad V, Geiger M, Lotter M et al (2003) Role of brachytherapy for head and neck cancer: retreatment in previously irradiated area. Brachytherapy 2:158–163</BibUnstructured>
              </Citation>
              <Citation ID="CR36">
                <CitationNumber>36</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Geiger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Strnad</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lotter</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Pulsed-dose rate brachytherapy with concomitant chemotherapy and interstitial hyperthermia in patients with recurrent head-and-neck cancer</ArticleTitle>
                  <JournalTitle>Brachytherapy</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <FirstPage>149</FirstPage>
                  <LastPage>153</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1538-4721(02)00056-9</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>15090278</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Geiger M, Strnad V, Lotter M et al (2002) Pulsed-dose rate brachytherapy with concomitant chemotherapy and interstitial hyperthermia in patients with recurrent head-and-neck cancer. Brachytherapy 1:149–153</BibUnstructured>
              </Citation>
              <Citation ID="CR37">
                <CitationNumber>37</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Donath</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Vuong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Shenouda</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">The potential uses of high-dose-rate brachytherapy in patients with head and neck cancer</ArticleTitle>
                  <JournalTitle>Eur Arch Otorhino-laryngol</JournalTitle>
                  <VolumeID>252</VolumeID>
                  <FirstPage>321</FirstPage>
                  <LastPage>324</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK287hsFeitw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Donath D, Vuong T, Shenouda G (1995) The potential uses of high-dose-rate brachytherapy in patients with head and neck cancer. Eur Arch Otorhino-laryngol 252:321–324</BibUnstructured>
              </Citation>
              <Citation ID="CR38">
                <CitationNumber>38</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TW</Initials>
                    <FamilyName>Leung</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SY</Initials>
                    <FamilyName>Tung</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WK</Initials>
                    <FamilyName>Sze</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>48</VolumeID>
                  <FirstPage>1331</FirstPage>
                  <LastPage>1338</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0360-3016(00)00776-8</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3M%2FnvVSqug%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>11121630</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Leung TW, Tung SY, Sze WK et al (2000) Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48:1331–1338</BibUnstructured>
              </Citation>
              <Citation ID="CR39">
                <CitationNumber>39</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JF</Initials>
                    <FamilyName>Moscoso</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Urken</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Dalton</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Simultaneous interstitial radiotherapy with regional or free-flap reconstruction, following salvage surgery of recurrent head and neck carcinoma. Analysis of complications</ArticleTitle>
                  <JournalTitle>Arch Otolaryngol Head Neck Surg</JournalTitle>
                  <VolumeID>120</VolumeID>
                  <FirstPage>965</FirstPage>
                  <LastPage>972</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1001/archotol.1994.01880330047009</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2czlsV2rsA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>8074824</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Moscoso JF, Urken ML, Dalton J et al (1994) Simultaneous interstitial radiotherapy with regional or free-flap reconstruction, following salvage surgery of recurrent head and neck carcinoma. Analysis of complications. Arch Otolaryngol Head Neck Surg 120:965–972</BibUnstructured>
              </Citation>
              <Citation ID="CR40">
                <CitationNumber>40</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PC</Initials>
                    <FamilyName>Levendag</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Meeuwis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AG</Initials>
                    <FamilyName>Visser</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Reirradiation of recurrent head and neck cancers: external and/or intersstitial radiation therapy</ArticleTitle>
                  <JournalTitle>Radiother Oncol</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>6</FirstPage>
                  <LastPage>15</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0167-8140(92)90299-A</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK387ktFCnuw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>1736334</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Levendag PC, Meeuwis C, Visser AG et al (1992) Reirradiation of recurrent head and neck cancers: external and/or intersstitial radiation therapy. Radiother Oncol 23:6–15</BibUnstructured>
              </Citation>
              <Citation ID="CR41">
                <CitationNumber>41</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Choo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Grimard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Esche</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Brachytherapy of neck metastases</ArticleTitle>
                  <JournalTitle>J Otolaryngol</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>54</FirstPage>
                  <LastPage>57</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK3s7ovVWiug%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>7680385</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Choo R, Grimard L, Esche B (1993) Brachytherapy of neck metastases. J Otolaryngol 22:54–57</BibUnstructured>
              </Citation>
              <Citation ID="CR42">
                <CitationNumber>42</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TW</Initials>
                    <FamilyName>Leung</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SY</Initials>
                    <FamilyName>Tung</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WK</Initials>
                    <FamilyName>Sze</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>47</VolumeID>
                  <FirstPage>405</FirstPage>
                  <LastPage>412</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0360-3016(00)00463-6</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3c3mtlyhtw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>10802367</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Leung TW, Tung SY, Sze WK et al (2000) Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 47:405–412</BibUnstructured>
              </Citation>
              <Citation ID="CR43">
                <CitationNumber>43</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Maulard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Housset</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Delanian</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Salvage split course brachytherapy for tonsil and soft palate carcinoma: treatment techniques and results</ArticleTitle>
                  <JournalTitle>Laryngoscope</JournalTitle>
                  <VolumeID>104</VolumeID>
                  <FirstPage>359</FirstPage>
                  <LastPage>363</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1288/00005537-199403000-00019</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2c7ntlWntw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>8127194</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Maulard C, Housset M, Delanian S et al (1994) Salvage split course brachytherapy for tonsil and soft palate carcinoma: treatment techniques and results. Laryngoscope 104:359–363</BibUnstructured>
              </Citation>
              <Citation ID="CR44">
                <CitationNumber>44</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Peiffert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Castelain</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Thomas</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Pulsed dose rate brachytherapyin head and neck cancers. Feasibility study of a French cooperative group</ArticleTitle>
                  <JournalTitle>Radiother Oncol</JournalTitle>
                  <VolumeID>58</VolumeID>
                  <FirstPage>71</FirstPage>
                  <LastPage>75</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0167-8140(00)00294-2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3M7otF2qsg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>11165684</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Peiffert D, Castelain B, Thomas L et al (2001) Pulsed dose rate brachytherapyin head and neck cancers. Feasibility study of a French cooperative group. Radiother Oncol 58:71–75</BibUnstructured>
              </Citation>
              <Citation ID="CR45">
                <CitationNumber>45</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Fujita</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Hirokawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Kashiwado</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications</ArticleTitle>
                  <JournalTitle>Int J Radiat Oncol Biol Phys</JournalTitle>
                  <VolumeID>44</VolumeID>
                  <FirstPage>767</FirstPage>
                  <LastPage>775</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0360-3016(99)00068-1</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1Mzhtlajtg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>10386633</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fujita M, Hirokawa Y, Kashiwado K et al (1999) Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications. Int J Radiat Oncol Biol Phys 44:767–775</BibUnstructured>
              </Citation>
              <Citation ID="CR46">
                <CitationNumber>46</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Schiefke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Hildebrandt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Pohlmann</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2008</Year>
                  <ArticleTitle Language="En">Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas</ArticleTitle>
                  <JournalTitle>J Craniomaxillofac Surg</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <FirstPage>285</FirstPage>
                  <LastPage>292</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.jcms.2007.08.009</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>18353667</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schiefke F, Hildebrandt G, Pohlmann S et al (2008) Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas. J Craniomaxillofac Surg 36:285–292</BibUnstructured>
              </Citation>
              <Citation ID="CR47">
                <CitationNumber>47</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Kakimoto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Inoe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Inoue</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">High-dose-rate interstitial brachytherapy for mobile tongue cancer: influence of the non-irradiated period</ArticleTitle>
                  <JournalTitle>Anticancer Res</JournalTitle>
                  <VolumeID>26</VolumeID>
                  <FirstPage>3933</FirstPage>
                  <LastPage>3937</LastPage>
                  <Occurrence Type="PID">
                    <Handle>17094424</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kakimoto N, Inoe T, Inoue T et al (2006) High-dose-rate interstitial brachytherapy for mobile tongue cancer: influence of the non-irradiated period. Anticancer Res 26:3933–3937</BibUnstructured>
              </Citation>
              <Citation ID="CR48">
                <CitationNumber>48</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Peiffert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Pernot</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Hoffstetter</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Reirradiation by interstitial brachytherapy alone of cancers of the oropharynx in previously irradiated areas</ArticleTitle>
                  <JournalTitle>Radiother Oncol</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <FirstPage>147</FirstPage>
                  <LastPage>148</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0167-8140(92)90026-Q</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK3s%2FmslWqsQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>1438937</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Peiffert D, Pernot M, Hoffstetter S et al (1992) Reirradiation by interstitial brachytherapy alone of cancers of the oropharynx in previously irradiated areas. Radiother Oncol 25:147–148</BibUnstructured>
              </Citation>
              <Citation ID="CR49">
                <CitationNumber>49</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WJ</Initials>
                    <FamilyName>Melzner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lotter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Sauer</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity?</ArticleTitle>
                  <JournalTitle>Radiother Oncol</JournalTitle>
                  <VolumeID>82</VolumeID>
                  <FirstPage>167</FirstPage>
                  <LastPage>173</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.radonc.2006.12.004</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>17258340</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Melzner WJ, Lotter M, Sauer R et al (2007) Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity? Radiother Oncol 82:167–173</BibUnstructured>
              </Citation>
              <Citation ID="CR50">
                <CitationNumber>50</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Lahmer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lotter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Kreppner</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">Protocol-based image-guided salvage brachytherapy. Early results in patients with local failure of prostate cancer after radiation therapy</ArticleTitle>
                  <JournalTitle>Strahlenther Onkol</JournalTitle>
                  <VolumeID>189</VolumeID>
                  <FirstPage>668</FirstPage>
                  <LastPage>674</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s00066-013-0373-7</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BC3sjnvVajtg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>23824103</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lahmer G, Lotter M, Kreppner S et al (2013) Protocol-based image-guided salvage brachytherapy. Early results in patients with local failure of prostate cancer after radiation therapy. Strahlenther Onkol 189:668–674</BibUnstructured>
              </Citation>
              <Citation ID="CR51">
                <CitationNumber>51</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Strnad</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Melzner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Geiger</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Role of interstitial PDR-brachytherapy in the treatment of oral and oropharyngeal cancer: a single-institute experience of 236 patients</ArticleTitle>
                  <JournalTitle>Strahlenther Onkol</JournalTitle>
                  <VolumeID>181</VolumeID>
                  <FirstPage>762</FirstPage>
                  <LastPage>767</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s00066-005-1424-5</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>16362785</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Strnad V, Melzner W, Geiger M et al (2005) Role of interstitial PDR-brachytherapy in the treatment of oral and oropharyngeal cancer: a single-institute experience of 236 patients. Strahlenther Onkol 181:762–767</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
